This article was written for Business of Cannabis by Scott Mazza, Co-Founder of Vitality CBD and Certified Headies
Uncertainty isn’t what hemp needs right now. As the market for legal hemp‑derived cannabinoids matures, peer‑reviewed research expands and serious brands raise production standards, the upcoming federal ban threatens to stall that momentum.
After the midnight passage of a policy rewrite that would eliminate roughly 95 % of the current market, the industry faces an entirely new landscape within six months. Most operators, farmers, and consumers are following the rules yet find themselves in the crosshairs of prohibition. This approach penalises the responsible actors and risks undoing nearly a decade of hemp progress.
Nonetheless, many insiders anticipate that regulation—rather than an outright ban—will emerge. If that occurs, we must rewrite the rulebook to foster a safer, higher‑quality market that rewards the producers who are already leading by example.
A small rule change with big repercussions
Producers (like me) worry that the blanket policy could render countless hemp‑derived cannabinoid products illegal.
Tucked into the spending bill that ended last year’s federal government shutdown, lawmakers added language capping finished hemp products at a maximum of 0.4 mg of total THC per consumer container—a stark departure from the longstanding 0.3 % THC by dry weight standard.
This is a small rule change with big repercussions. Full‑spectrum CBD naturally contains trace concentrations of delta‑9 THC, which accumulate across a container. Our own third‑party‑tested tincture, for example, contains about 40 mg THC per unit—roughly 100 times the incoming limit. Moreover, legislators banned any cannabinoid synthesised outside the plant, clearly targeting compounds such as delta‑8 THC. Together, these measures could erase the vast majority of the hemp market, a sector valued at approximately $28 billion and supporting more than 300,000 jobs.
Raw hemp prices have already slipped as processors and manufacturers hesitate, fearing unusable inventory. Farmers remain uncertain whether planting hemp will remain viable, and producers are torn between investing in improvement and bracing for a possible market shutdown.
CBD & Hemp
DEA Formalises HHC Ban as US Farm Bill Offers No Repreive for Cannabinoid Market
As the federal campaign to clamp down on intoxicating hemp in the US rolls on, the Drug Enforcement Administration (DEA) has officially designated hexahydrocannabinol (HHC) a Schedule I substance. It […]
Read the Story →
A maturing market under threat
This situation is unfortunate because hemp is experiencing genuine momentum. Rather than the CBD‑laden energy drinks found at gas stations, mature operators are carving out a wellness niche that treats hemp with seriousness. Consumers using CBD for better sleep now prioritise quality markers such as organic certification and independent lab testing, creating a positive feedback loop that elevates best practices, encourages self‑regulation, and weeds out bad actors.
The science increasingly supports these trends. Since the 2018 Farm Bill removed federal barriers, laboratories have corroborated anecdotal reports, documenting hemp’s benefits for anxiety, inflammation, and other conditions. This evidence also undermines the claim that CBD isolate will remain legal after the proposed change; isolates lack the full range of phytochemicals that produce the entourage effect, which research shows enhances therapeutic outcomes.
Of course, the sector isn’t flawless. Some operators still cut corners on organic practices or mislabel potency, and a few “cowboys” chase quick profits with untested, potentially hazardous products. However, answering these issues with a restrictive blanket threshold that fails to differentiate responsible producers from newcomers would punish a five‑year‑old quality operation the same as a brand selling untested gummies last month.
The revised federal stance essentially kneecaps an industry that sustains hundreds of thousands of jobs and generates billions of dollars—a reality that is both politically and practically difficult to maintain. Already, some lawmakers are discussing a two‑year extension, with November 12 emerging as a potential forcing function that could compel Congress to craft proper hemp regulations.
Build the rules around the right people
Effective regulation begins with clear, enforceable compliance expectations. The Hemp Enforcement, Modernization, and Protection (HEMP) Act, introduced in January, proposes FDA oversight. A genuine government watchdog could swiftly remove products contaminated with pesticides, heavy metals, or other adulterants.
Coupled with routine testing and a proven compliance record, there is a foundation for a federal seal of hemp quality. This visible, consumer‑facing badge could reward growers and manufacturers that achieve organic certification, accurate labeling, and transparent testing—mirroring how other established consumer goods categories operate.
Finally, any future framework should be dosage‑based rather than a blanket cap. The 0.4 mg finished‑product limit makes no distinction between a sleep‑aid tincture and a high‑dose intoxicant. Different products serve different consumer needs, and regulations ought to reflect that nuance.
Prohibition answers the wrong question. Instead, we need to protect—not punish—the operators, farmers, and consumers who are driving this emerging wellness segment. If policymakers wish to reshape the industry, they should engage in good‑faith dialogue, base decisions on science, and involve the stakeholders who have already demonstrated they can operate responsibly.
For the original source, see: Here
